|
RNF138 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.682400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.872600E-01 |
| Normal-vs-Stage2 |
5.089600E-01 |
| Normal-vs-Stage3 |
7.203600E-01 |
| Normal-vs-Stage4 |
8.251600E-01 |
| Stage1-vs-Stage2 |
8.930400E-01 |
| Stage1-vs-Stage3 |
1.168790E-01 |
| Stage1-vs-Stage4 |
1.336950E-01 |
| Stage2-vs-Stage3 |
3.765400E-01 |
| Stage2-vs-Stage4 |
4.222800E-01 |
| Stage3-vs-Stage4 |
8.593400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.851800E-01 |
| Normal-vs-AfricanAmerican |
4.831200E-01 |
| Normal-vs-Asian |
9.583400E-01 |
| Caucasian-vs-AfricanAmerican |
9.973500E-02 |
| Caucasian-vs-Asian |
8.744200E-01 |
| AfricanAmerican-vs-Asian |
6.656400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.966400E-01 |
| Normal-vs-Female |
3.363400E-01 |
| Male-vs-Female |
3.283000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.289400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.370200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.457800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.908800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.181600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.233400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.084400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.075200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.216200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.790800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.893830E-01 |
| Normal-vs-Grade 2 |
6.790500E-02 |
| Normal-vs-Grade 3 |
5.861800E-01 |
| Normal-vs-Grade 4 |
1.296450E-01 |
| Grade 1-vs-Grade 2 |
7.361400E-01 |
| Grade 1-vs-Grade 3 |
6.364300E-02 |
| Grade 1-vs-Grade 4 |
2.110100E-02 |
| Grade 2-vs-Grade 3 |
3.540900E-03 |
| Grade 2-vs-Grade 4 |
4.587500E-04 |
| Grade 3-vs-Grade 4 |
1.427600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.697520E-02 |
| Normal-vs-ccB subtype |
4.426400E-01 |
| ccA subtype-vs-ccB subtype |
3.035000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.139400E-01 |
| Normal-vs-N1 |
8.805000E-01 |
| N0-vs-N1 |
8.777000E-01 |
|
|
